Early Prediction of Respiratory and Autonomic Complications of GBS Using Neuromuscular Ultrasound
1 other identifier
observational
100
1 country
1
Brief Summary
Neuromuscular US will be a good and non invasive predictor for respiratory and autonomic dysfunctions in GBS through evaluation of diaphragmatic thickness, phrenic and vagus nerve cross sectional area.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
November 12, 2019
CompletedFirst Posted
Study publicly available on registry
November 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2020
CompletedNovember 18, 2019
November 1, 2019
1 year
November 12, 2019
November 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neuromuscular ultrasound
Sensitivity and specificity of US in predicting respiratory and autonomic complications in Guillain Barre Syndrome
24-48 hours
Secondary Outcomes (2)
Respiratory and autonomic complications
1 month
Correlation between clinical scores and reference US values
48-72 hours
Study Arms (1)
Respiratory and autonomic complications of GBS
Early detection of respiratory failure is among the main challenges raised by the management of GBS. Careful monitoring by an experienced team of nurses and physicians is crucial. The classic signs of respiratory failure occur late, and the early manifestations consist only of tachypnea, tachycardia, air hunger, broken sentences, and a need to pause between sentences; later, use of the accessory respiratory muscles, paradoxical breathing, and orthopnea indicate severe diaphragmatic weakness. Autonomic dysfunction occurred in the affected patients, including cardiac arrhythmia, hypertension or hypotension, ileus, and urinary retention.
Interventions
Neuromuscular ultrasound refers to a field in medicine in which ultrasound is used to diagnosis and guide treatment for people with neuromuscular diseases. Neuromuscular ultrasound is often combined with electrodiagnosis, and particularly nerve conduction studies and EMG, to improve the accuracy of diagnosis and add anatomic information to the functional information obtained with electrodiagnosis. It has been demonstrated that neuromuscular ultrasound adds value to the diagnosis of nerve disease in over 80% of cases.
Eligibility Criteria
100 Patients that will fulfill the published diagnostic criteria of GBS.
You may qualify if:
- Patients that will fulfill the published diagnostic criteria of GBS.
- Age: 18-65
- Both sexes
You may not qualify if:
- History of cardiopulmonary dysfunction
- BMI\>30 Kg/m2
- Renal or hepatic failure
- Sepsis
- Autonomic or respiratory dysfunction from the start
- Patients with hypo- or hyperkalemic paralysis, porphyria, viral myositis, botulism, diphtheritic neuropathy, and history of potential toxic exposure were excluded.
- Abnormal pulmonary function test from the start.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mansoura University Hospital
Al Mansurah, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Esmael M Ahmed, MD
Assistant Prof of Neurology
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Prof of Neurology
Study Record Dates
First Submitted
November 12, 2019
First Posted
November 18, 2019
Study Start
July 1, 2019
Primary Completion
July 1, 2020
Study Completion
November 1, 2020
Last Updated
November 18, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share